By Will Feuer


Danaher expects a key sales figure to fall in the third quarter and lowered its full-year forecast.

The health-care and laboratory-supply company expects third-quarter adjusted base business core sales, which strips out sales of products related to Covid-19 as well as currency fluctuations and other noisy factors, to fall by a low-single digit percentage from a year ago.

For the full year, Danaher expects that figure to be up by a low-single digit percentage. That is down from guidance offered in April for full-year adjusted base business core sales to be up by a mid-single digit percentage.

In the second quarter, adjusted base business core sales rose by 2%, even as non-adjusted sales fell by 7.5%.

Chief Executive Rainer Blair said the company faces a "more dynamic operating environment."

Shares fell 3.9% to $248.00 in premarket trading.

Write to Will Feuer at Will.Feuer@wsj.com


(END) Dow Jones Newswires

07-25-23 0638ET